Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
protection for cancer drug Glivec and set a benchmark for intellectual property cases. Commerce and Industry Minister Anand Sharma said India would revoke drug patents if outbreaks of serious diseases or pandemics made it necessary, defending a Supreme Court ruling against Swiss drug firm Novartis. The apex court dealt a blow to Western drugmakers on April 1 when it threw out Novartis' bid to win patent protection for cancer drug Glivec and set a benchmark for intellectual property cases in a country where many patented drugs are unaffordable for most of the population of 1.2 billion. Speaking during a visit to the World Intellectual Property Organization in Geneva, Sharma said the court decision was "absolutely justified" under the intellectual property rules of the World Trade Organization, known as the TRIPS agreement.